Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03489707 · ClinicalTrials.gov registry record · NA
The Prevent Anal Cancer Self-Swab Study
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 253
- Enrollment target
NCT03489707 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 253 participants.
The verdict
NCT03489707, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 253 participants
- Enrollment target
Study Summary
The purpose of this research study is to find ways to screen for anal cancer among gay, bisexual, and other men who have sex with men (MSM) and transgender persons. This study will try to find out if persons will do annual anal cancer screening, what factors are associated with repeated screening, and how this affects a person's decision to have high-resolution anoscopy.
Interventions
- BEHAVIORAL Home-based human papillomavirus (HPV) DNA screening
- BEHAVIORAL Clinic-based human papillomavirus (HPV) DNA screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2020-01-09 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03489707
The ClinicalTrials.gov registry entry for NCT03489707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Home-based human papillomavirus (HPV) DNA screening is the first listed.
NCT03489707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03489707 about?
NCT03489707 is a clinical study titled "The Prevent Anal Cancer Self-Swab Study". The purpose of this research study is to find ways to screen for anal cancer among gay, bisexual, and other men who have sex with men (MSM) and transgender persons. This study will try to find out if persons will do annual anal cancer screening, what factors are associated with repeated screening, a...
What is the current status of trial NCT03489707?
This trial is currently completed. It is a NA study. The enrollment target is 253 participants. The study started on 2020-01-09. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT03489707?
The interventions under investigation include: Home-based human papillomavirus (HPV) DNA screening (BEHAVIORAL), Clinic-based human papillomavirus (HPV) DNA screening (BEHAVIORAL).
Who is sponsoring clinical trial NCT03489707?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.